Owlstone medical

Owlstone medical

Owlstone medical

Cancer Breathalyzer #save100klives
Type
B2b
Founded
2005
Raised
$19.9M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$15,000,000
Venture capital - 2018
Horizons Ventures Aviva Ventures
£4,000,000
Venture capital - 2017
Aviva Ventures
Team Size
10+
Employees
$15,000,000 Venture capital
The Times

Li Ka-shing contributes to £11m boost for cancer 'breath test' company Owlstone Medical

£4,000,000 Venture capital
The Telegraph

Aviva invests £4m in cancer breath tests

FinSMEs

Owlstone Medical Raises Approx. £9.3M in Funding

Health Funding
owlstonenanotech , FinSMEs

Owlstone Medical closes $7M (£4.9M) investment to commercialize disease breathalyzer